Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
1.
BMC Cancer ; 20(1): 227, 2020 Mar 17.
Artículo en Inglés | MEDLINE | ID: mdl-32183748

RESUMEN

BACKGROUND: As the number of PET/CT scanners increases and FDG PET/CT becomes a common imaging modality for oncology, the demands for automated detection systems on artificial intelligence (AI) to prevent human oversight and misdiagnosis are rapidly growing. We aimed to develop a convolutional neural network (CNN)-based system that can classify whole-body FDG PET as 1) benign, 2) malignant or 3) equivocal. METHODS: This retrospective study investigated 3485 sequential patients with malignant or suspected malignant disease, who underwent whole-body FDG PET/CT at our institute. All the cases were classified into the 3 categories by a nuclear medicine physician. A residual network (ResNet)-based CNN architecture was built for classifying patients into the 3 categories. In addition, we performed a region-based analysis of CNN (head-and-neck, chest, abdomen, and pelvic region). RESULTS: There were 1280 (37%), 1450 (42%), and 755 (22%) patients classified as benign, malignant and equivocal, respectively. In the patient-based analysis, CNN predicted benign, malignant and equivocal images with 99.4, 99.4, and 87.5% accuracy, respectively. In region-based analysis, the prediction was correct with the probability of 97.3% (head-and-neck), 96.6% (chest), 92.8% (abdomen) and 99.6% (pelvic region), respectively. CONCLUSION: The CNN-based system reliably classified FDG PET images into 3 categories, indicating that it could be helpful for physicians as a double-checking system to prevent oversight and misdiagnosis.


Asunto(s)
Neoplasias Abdominales/diagnóstico por imagen , Neoplasias de Cabeza y Cuello/diagnóstico por imagen , Redes Neurales de la Computación , Neoplasias Pélvicas/diagnóstico por imagen , Tomografía Computarizada por Tomografía de Emisión de Positrones/tendencias , Neoplasias Torácicas/diagnóstico por imagen , Neoplasias Abdominales/clasificación , Adulto , Anciano , Anciano de 80 o más Años , Inteligencia Artificial , Femenino , Fluorodesoxiglucosa F18 , Neoplasias de Cabeza y Cuello/clasificación , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Pélvicas/clasificación , Neoplasias Torácicas/clasificación , Adulto Joven
2.
J Cancer Res Ther ; 11(4): 1028, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26881606

RESUMEN

Desmoplastic small round cell tumor (DSRCT) is rare and highly malignant neoplasm. DSRCT affects usually young males but can occur in adults also. Intra-abdominal pelvic region is the preferred site. Though confirmed by histology, immunohistochemistry (IHC) plays a key role in diagnosis. IHC profile is characteristic, it shows simultaneous expression of epithelial (epithelial membrane antigen (EMA) and cytokeratin (CK)), muscular (desmin), and neural (neuron-specific enolase) markers. Many cases of DSRCT are diagnosed as poorly differentiated carcinoma due to lack of proper panel of IHC. It is difficult to predict if there has been a true increase in incidence. Prognosis is uncertain in such an aggressive neoplasm as chemotherapy (CT) or radiotherapy (RT) shows various outcomes. Here in; we report four cases, all of which showed diagnostic dilemma and uncertain prognosis.


Asunto(s)
Neoplasias Abdominales/diagnóstico , Biomarcadores de Tumor/metabolismo , Tumor Desmoplásico de Células Pequeñas Redondas/diagnóstico , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/tratamiento farmacológico , Neoplasias Abdominales/metabolismo , Adolescente , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Niño , Preescolar , Tumor Desmoplásico de Células Pequeñas Redondas/clasificación , Tumor Desmoplásico de Células Pequeñas Redondas/tratamiento farmacológico , Tumor Desmoplásico de Células Pequeñas Redondas/metabolismo , Femenino , Humanos , Técnicas para Inmunoenzimas , Masculino , Pronóstico
3.
Br J Radiol ; 87(1041): 20140116, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24983762

RESUMEN

Teratomas comprise a spectrum of tumours that have striking imaging appearances and are commonly considered when evaluating a mass in the female pelvis. A subgroup of these tumours located in an extragonadal abdominopelvic location, in contrast, are extremely rare and can affect both sexes. Extragonadal teratomas can occur at all ages, are particularly unusual in adults and can cause confusion in the differential diagnosis, especially in children. Familiarity with the imaging features of the spectrum of teratomas within the abdominal cavity is therefore of great importance, as radiological diagnosis can guide treatment, prevent delays in diagnosis and avoid sequelae. This article summarizes the radiological appearances of these rare extragonadal tumours in adults in relation to their pathology, malignant potential, location and behaviour. Although uncommon, teratomas should be considered in the differential diagnosis of extragonadal abdominal masses, particularly in young adults.


Asunto(s)
Neoplasias Abdominales/diagnóstico , Neoplasias Pélvicas/diagnóstico , Teratoma/diagnóstico , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/patología , Adulto , Niño , Medios de Contraste , Diagnóstico Diferencial , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Neoplasias Pélvicas/clasificación , Neoplasias Pélvicas/patología , Teratoma/clasificación , Teratoma/patología
4.
Pediatr Radiol ; 43(7): 836-45, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23666206

RESUMEN

BACKGROUND: Solid malignant tumors are more highly cellular than benign lesions and hence have a restricted diffusion of water molecules. OBJECTIVE: To evaluate whether diffusion-weighted MR imaging (DWI) can differentiate between benign and malignant pediatric abdominal tumors. MATERIALS AND METHODS: We retrospectively analyzed DWI scans of 68 consecutive children with 39 benign and 34 malignant abdominal masses. To calculate the apparent diffusion coefficient (ADC) maps and ADC values, we used 1.5-T sequences at TR/TE/b-value of 5,250-7,500/54-64/b = 0, 500 and 3-T sequences at 3,500-4,000/66-73/b = 0, 500, 800. ADC values were compared between benign and malignant and between data derived at 1.5 tesla (T) and at 3 tesla magnetic field strength, using the Mann-Whitney-Wilcoxon test, ANOVA and a receiver operating curve (ROC) analysis. RESULTS: There was no significant difference in ADC values obtained at 1.5 T and 3 T (P = 0.962). Mean ADC values (× 10(-3) mm(2)/s) were 1.07 for solid malignant tumors, 1.6 for solid benign tumors, 2.9 for necrotic portions of malignant tumors and 3.1 for cystic benign lesions. The differences between malignant and benign solid tumors were statistically significant (P = 0.000025). ROC analysis revealed an optimal cut-off ADC value for differentiating malignant and benign solid tumors as 1.29 with excellent inter-observer reliability (alpha score 0.88). CONCLUSION: DWI scans and ADC values can contribute to distinguishing between benign and malignant pediatric abdominal tumors.


Asunto(s)
Neoplasias Abdominales/clasificación , Neoplasias Abdominales/patología , Imagen de Difusión por Resonancia Magnética/métodos , Adolescente , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Adulto Joven
5.
In. Valls Pérez, Orlando; Parrilla Delgado, Maria Edelmira; Valls Figueroa, Carmen. Imaginología de urgencia. Valor de los algoritmos diagnósticos. Tomo.II. La Habana, Ecimed, 2012. , ilus.
Monografía en Español | CUMED | ID: cum-54051
6.
Am J Surg Pathol ; 35(1): 135-44, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21164297

RESUMEN

Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm of intermediate biological potential, which may recur and rarely metastasize. Pathologic features do not correlate well with behavior. Approximately 50% of conventional IMTs harbor ALK gene rearrangement and overexpress ALK, most showing diffuse cytoplasmic staining. Rare IMTs with a distinct nuclear membrane or perinuclear pattern of ALK staining and epithelioid or round cell morphology have been reported. These cases pursued an aggressive clinical course, suggesting that such patterns may predict malignant behavior. We describe 11 cases of IMT with epithelioid morphology and a nuclear membrane or perinuclear pattern of immunostaining for ALK. Ten patients were male and 1 was female, ranging from 7 months to 63 years in age (median, 39 y). All tumors were intra-abdominal; most arose in the mesentery or omentum, measuring 8 to 26 cm (median, 15 cm). Six tumors were multifocal at presentation. The tumors were composed predominantly of sheets of round-to-epithelioid cells with vesicular nuclei, large nucleoli, and amphophilic-to-eosinophilic cytoplasm. In all cases, a minor spindle cell component was present. Nine tumors had abundant myxoid stroma. In 7 cases neutrophils were prominent and in 3 cases lymphocytes were prominent. Plasma cells were often absent. Median mitotic rate was 4/10 HPF; 6 tumors had necrosis. By immunohistochemistry, all tumors were positive for ALK, 9 tumors showing a nuclear membrane staining pattern and 2 tumors showing a cytoplasmic pattern with perinuclear accentuation. Other positive markers were desmin (10 of 11), focal smooth muscle actin (4 of 8), and CD30 (8 of 8). All tumors were negative for MYF4, caldesmon, keratins, EMA, and S-100. Fluorescence in situ hybridization was positive for ALK gene rearrangement in 9 cases, and in 3 cases tested, a RANBP2-ALK fusion was detected by reverse transcription polymerase chain reaction. Ten patients underwent surgical resection; 1 patient was inoperable. Follow-up was available for 8 patients and ranged from 3 to 40 months (median, 13 mo). All patients experienced rapid local recurrences; 4 patients had multiple recurrences. Eight patients were treated with postoperative chemotherapy; 2 patients received additional radiotherapy. Two patients also developed metastases (both patients developed metastases to the liver; 1 patient developed metastases to the lung and lymph nodes as well). Thus far, 5 patients died of disease, 2 patients are alive with disease, and 1 patient, treated with an experimental ALK inhibitor, has no evidence of disease. In summary, the epithelioid variant of IMT with nuclear membrane or perinuclear ALK is a distinctive intra-abdominal sarcoma with a predilection for male patients. Unlike conventional IMT, abundant myxoid stroma and prominent neutrophils are common. These tumors pursue an aggressive course with rapid local recurrences and are frequently fatal. We propose the designation "epithelioid inflammatory myofibroblastic sarcoma" to convey both the malignant behavior of these tumors and their close relationship with IMT.


Asunto(s)
Neoplasias Abdominales/enzimología , Células Epitelioides/enzimología , Inflamación/enzimología , Miofibroblastos/enzimología , Membrana Nuclear/enzimología , Proteínas Tirosina Quinasas/análisis , Sarcoma/enzimología , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/genética , Neoplasias Abdominales/mortalidad , Neoplasias Abdominales/patología , Neoplasias Abdominales/terapia , Adulto , Quinasa de Linfoma Anaplásico , Biomarcadores de Tumor/análisis , Niño , Análisis Citogenético , Células Epitelioides/patología , Femenino , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Lactante , Inflamación/genética , Inflamación/patología , Masculino , Persona de Mediana Edad , Miofibroblastos/patología , Invasividad Neoplásica , Recurrencia Local de Neoplasia , Proteínas Tirosina Quinasas/genética , Proteínas Tirosina Quinasas Receptoras , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sarcoma/clasificación , Sarcoma/genética , Sarcoma/mortalidad , Sarcoma/patología , Sarcoma/terapia , Terminología como Asunto , Factores de Tiempo , Resultado del Tratamiento
7.
Pediatr Hematol Oncol ; 23(3): 167-76, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16526117

RESUMEN

Non-Hodgkin lymphoma (NHL) represents one of the most rapidly growing malignancies in childhood and adolescence. About 80% of patients now are cured with adequate treatment. Serious complications at presentation due to tumor lysis syndrome or local tumor effects are commonly observed. Thus, a rapid diagnosis with the least invasive procedure enabling the initiation of early and specific therapy is necessary to diminish early fatality or persistent impairment. In 56 centrally registered patients with NHL, cytomorphologic analyses (FAB criteria) of May-Grünwald-Giemsa-stained touch imprints or malignant effusions and flow cytometric immunophenotyping (EGIL criteria) of fresh cell suspensions with a standardized panel of monoclonal antibodies were performed. The authors identified 23 patients with Burkitt lymphoma by the combination of FAB L3 morphology and a mature B-cell phenotype and 22 patients with lymphoblastic lymphoma by FAB L1/L2 morphology and a T-/B-cell precursor phenotype. They also found 11 patients with large cell lymphomas, 3 of them with anaplastic large cell lymphoma (T-cell phenotype; NPM/ALK-positive). In the remaining 8 patients diffuse large B-cell lymphoma was suspected by the combined use of cytologic and immunophenotypic findings (mature B-cell phenotype). In all cases with available solid tumor material (n = 42/56) the preliminary diagnosis was confirmed by histopathology. Burkitt lymphoma, lymphoblastic lymphoma, and, in a few cases, some large cell lymphomas could be classified reliably by cytomorphology and immunophenotyping of freshly obtained tumor cell material, enabling an early start of specific lymphoma treatment.


Asunto(s)
Técnicas Citológicas , Citometría de Flujo , Inmunofenotipificación , Linfoma no Hodgkin/diagnóstico , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/diagnóstico , Neoplasias Abdominales/patología , Adolescente , Antígenos CD/análisis , Austria/epidemiología , Biopsia con Aguja Fina , Linfoma de Burkitt/diagnóstico , Linfoma de Burkitt/patología , Núcleo Celular/ultraestructura , Tamaño de la Célula , Niño , Preescolar , Citoplasma/ultraestructura , Diagnóstico Precoz , Estudios de Factibilidad , Femenino , Humanos , Hibridación Fluorescente in Situ , Lactante , Subgrupos Linfocitarios/patología , Linfoma de Células B Grandes Difuso/diagnóstico , Linfoma de Células B Grandes Difuso/patología , Linfoma no Hodgkin/clasificación , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/patología , Masculino , Neoplasias del Mediastino/clasificación , Neoplasias del Mediastino/diagnóstico , Neoplasias del Mediastino/patología , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Estudios Prospectivos , Coloración y Etiquetado
11.
Pediatr Surg Int ; 16(5-6): 458-61, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10955594

RESUMEN

Lipoblastoma is a rare adipose tumor occurring exclusively in childhood. There have been no reports of metastases, making the designation "blastoma" confusing, since this term is usually reserved for malignant tumors. Two recent cases treated at our institution confirm its benign nature. In addition, a review of the literature supports the idea that the tumor may more accurately be described as an "infantile lipoma". Infantile lipoma better reflects many of the tumor's characteristics such as, its early occurrence, it's ability to mature into a simple lipoma, it's cellular composition of mainly mature adipocytes, and its benign course. Although lipoblastoma is an uncommonly encountered tumor, making an effort to change its name to infantile lipoma will result in a more a accurate term that will facilitate treatment.


Asunto(s)
Neoplasias Abdominales/diagnóstico , Lipoma/diagnóstico , Terminología como Asunto , Neoplasias Torácicas/diagnóstico , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/cirugía , Femenino , Humanos , Lactante , Lipoma/clasificación , Lipoma/cirugía , Imagen por Resonancia Magnética , Masculino , Neoplasias Torácicas/clasificación , Neoplasias Torácicas/cirugía , Tomografía Computarizada por Rayos X
12.
Surgery ; 125(1): 67-72, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9889800

RESUMEN

BACKGROUND: Laparoscopy in patients with intra-abdominal malignancy remains controversial. This study evaluates the incidence of tumor recurrence at the port site after laparoscopy in patients with intra-abdominal malignancy. METHODS: The medical records of all patients with nongynecologic malignancies who underwent laparoscopic procedures between May 1, 1990, and June 30, 1996, at the University of Texas M.D. Anderson Cancer Center were reviewed. Data on extent of tumor, histologic findings, primary location, procedures performed, and complications were recorded. RESULTS: During this time, 533 patients with known intra-abdominal malignancies underwent laparoscopy. Mean follow-up time was 13.2 +/- 0.5 months (range 1 to 71 months; median 10.6 months). Four recurrences at the port site were identified (0.8%). Three of these patients had advanced intra-abdominal disease at the time of laparoscopy; 1 patient without advanced disease at the time of laparoscopy had a recurrence at the port site as the only site of recurrent disease (0.19%). The incidence of port site recurrences among patients with advanced intra-abdominal disease at the time of laparoscopy (3/71) was significantly greater than the risk of development of a recurrence at the port site among patients without advanced intra-abdominal disease at the time of laparoscopy (1/462; P < .0003, by chi-square analysis). CONCLUSION: Recurrence at the port site is very rare. When implantation at the port site does occur, it is most commonly associated with advanced intra-abdominal disease.


Asunto(s)
Neoplasias Abdominales/cirugía , Laparoscopía , Recurrencia Local de Neoplasia/epidemiología , Neoplasias Abdominales/clasificación , Adenocarcinoma/cirugía , Adulto , Neoplasias del Colon/cirugía , Bases de Datos como Asunto , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Laparoscopía/efectos adversos , Linfoma/cirugía , Masculino , Neoplasias Pancreáticas/cirugía , Estudios Retrospectivos , Neoplasias Gástricas/cirugía , Factores de Tiempo
13.
J Med Syst ; 22(2): 55-62, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9571511

RESUMEN

From August 1983 through March 1995, 204,099 people received ultrasonic mass survey of the abdomen for the first time. Among these examinees, 631 (0.31%) malignant neoplasm cases, such as 201 hepatocellular carcinoma (HCC), 81 gallbladder (GB) cancer, 57 pancreatic cancer, and 169 renal cell carcinoma (RCC), were detected. Three hundred seventy six out of 590 cases (64%), excluding chronic leukemia cases and metastatic liver cancer cases, were surgically resected. The resection rate of HCC, GB cancer, pancreatic cancer, and RCC were 25%, 88%, 49%, and 99%, respectively. The cumulative survival rate of the 376 resected cases was 79.5% at 10 years. The cumulative survival rates of resected cases of HCC, GB cancer, pancreatic cancer and cumulative survival rates of resected cases of HCC, GB cancer, pancreatic cancer and RCC were 34% at ten years, 83% at 10 years, 49% at 7 years, and 99% at 10 years, respectively. Ultrasonic mass survey is dramatically useful for early detection of various kinds of abdominal cancers, especially RCC and GB cancer. From now on, many earlier abdominal cancers will be found by establishing and promoting ultrasonic mass survey systems.


Asunto(s)
Neoplasias del Sistema Digestivo/diagnóstico por imagen , Neoplasias del Sistema Digestivo/epidemiología , Neoplasias Renales/diagnóstico por imagen , Neoplasias Renales/epidemiología , Tamizaje Masivo/estadística & datos numéricos , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/diagnóstico por imagen , Neoplasias Abdominales/epidemiología , Neoplasias Abdominales/terapia , Distribución por Edad , Anciano , Carcinoma Hepatocelular/diagnóstico por imagen , Carcinoma Hepatocelular/epidemiología , Carcinoma Hepatocelular/terapia , Carcinoma de Células Renales/diagnóstico por imagen , Carcinoma de Células Renales/epidemiología , Carcinoma de Células Renales/terapia , Distribución de Chi-Cuadrado , Neoplasias del Sistema Digestivo/terapia , Femenino , Humanos , Incidencia , Japón/epidemiología , Neoplasias Renales/terapia , Masculino , Persona de Mediana Edad , Pronóstico , Distribución por Sexo , Tasa de Supervivencia , Ultrasonografía
14.
Am J Surg Pathol ; 21(12): 1466-73, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9414190

RESUMEN

We reclassified 720 nonmedullary invasive thyroid carcinomas diagnosed and treated between 1975 and 1993. Twenty-seven cases met the criteria of insular carcinoma and 29 cases those of widely invasive follicular carcinoma. Comparison of these histotypes with respect to pathologic stage and overall, relative, and visceral metastasis-free survival showed a significant association between histotype and pT and pN categories. In particular, pT4 (p < 0.001) and pN1 (p < 0.001) categories were more frequent in the insular carcinoma histotype. By contrast, no significant differences in overall, relative, or visceral metastasis-free survival were observed between insular carcinoma and widely invasive follicular carcinoma. Molecular analysis by polymerase chain reaction-single-strand conformation polymorphism demonstrated RAS gene family point mutations in five of eight cases analyzed in each of the two histotypes, with a high proportion of CAA-->AAA transversion at codon 61 of the N-RAS gene in insular carcinoma. These findings suggest that insular carcinoma represents a de novo entity distinct from widely invasive follicular carcinoma, that widely invasive follicular carcinoma has biologic characteristics more consistent with poorly differentiated than well-differentiated carcinomas, and that both insular carcinoma and widely invasive follicular carcinoma share similar molecular alterations.


Asunto(s)
Adenocarcinoma Folicular/clasificación , Adenocarcinoma Folicular/patología , Genes ras , Mutación Puntual , Neoplasias de la Tiroides/clasificación , Neoplasias de la Tiroides/patología , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/patología , Neoplasias Abdominales/secundario , Adenocarcinoma Folicular/genética , Adenocarcinoma Folicular/mortalidad , Adolescente , Adulto , Anciano , Codón , Cartilla de ADN , Femenino , Humanos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Metástasis de la Neoplasia , Recurrencia , Estudios Retrospectivos , Tasa de Supervivencia , Neoplasias de la Tiroides/genética , Neoplasias de la Tiroides/mortalidad , Factores de Tiempo
16.
Int J Gynecol Pathol ; 15(2): 171-6, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8786208

RESUMEN

In 1977, a case report was published describing a 28-year-old women with an endometrial stromal tumor that showed foci of myogenic differentiation. The term "stromomyoma" was introduced to encompass both this type of neoplasm as well as "uterine neoplasms resembling ovarian sex-cord tumors" (UTROSCTs). More than 17 years later, the tumor recurred, involving the right ovary, sigmoid colon, small bowel, abdominal wall and omentum. The histologic and electron microscopic similarities between the recurrent tumor and the primary neoplasm were confirmed. Applying the recent classification and diagnostic criteria of endometrial mesenchymal neoplasms, we have concluded that this tumor was a low-grade endometrial stromal sarcoma (LGSS). The formerly proposed term "stromomyoma" implies a benign tumor, in contrast to the obviously malignant nature of this particular tumor. Focal myogenic differentiation of LGSS is not an uncommon finding and does not warrant a separate diagnostic or prognostic entity. UTROSCTs and endometrial stromal sarcomas are two separate diagnostic entities, and combining them under an inclusive terminology is not appropriate.


Asunto(s)
Neoplasias Abdominales/secundario , Neoplasias Endometriales/patología , Neoplasias Intestinales/secundario , Músculo Liso/patología , Epiplón/patología , Neoplasias Ováricas/secundario , Neoplasias Peritoneales/secundario , Sarcoma Estromático Endometrial/secundario , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/ultraestructura , Adulto , Biopsia , División Celular , Neoplasias Endometriales/clasificación , Neoplasias Endometriales/ultraestructura , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Intestinales/clasificación , Neoplasias Intestinales/ultraestructura , Músculo Liso/ultraestructura , Neoplasias Ováricas/clasificación , Neoplasias Ováricas/ultraestructura , Neoplasias Peritoneales/clasificación , Neoplasias Peritoneales/ultraestructura , Sarcoma Estromático Endometrial/clasificación , Sarcoma Estromático Endometrial/ultraestructura , Terminología como Asunto
17.
Rev. argent. radiol ; 59(3): 169-72, jul.-sept. 1995. ilus
Artículo en Español | LILACS | ID: lil-166004

RESUMEN

Entre el 1 de enero de 1992 y el 31 de diciembre de 1993, se realizaron 4.586 tomografías abdóminopelvianas, de las cuales 142 (3,1 por ciento) presentaron masas gigantes (mayores de 10 cm). Las masas gigantes se presentaron con mayor frecuencia entre la sexta y séptima década de la vida. Del total de pacientes, 81 fueron de sexo femenino (57,04 por ciento) y 61 de sexo masculino (42,96 por ciento). Los signos y síntomas que acompañaron a cada paciente fueron muy variados como así también la localización de dichas masas. La TC tuvo una sensibilidad del 100 por ciento para confirmar y diagnosticar la presencia de masas gigantes. El análisis semiológico de estas masas por TC, nos ha permitido determinar el órgano comprometido en un 97,88 por ciento; caracterizar el contenido y arquitectura del tumor en el 100 por ciento de los casos y evocar la naturaleza de las lesiones, refiriéndose al carácter benigno y maligno de las mismas en el 92,25 por ciento


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Adolescente , Adulto , Persona de Mediana Edad , Neoplasias Abdominales/diagnóstico , Diagnóstico Diferencial , Neoplasias Pélvicas/diagnóstico , Tomografía Computarizada por Rayos X/estadística & datos numéricos , Neoplasias Abdominales , Neoplasias Abdominales/clasificación , Neoplasias Pélvicas , Neoplasias Pélvicas/clasificación , Tomografía Computarizada por Rayos X/métodos
18.
Rev. argent. radiol ; 59(3): 169-72, jul.-sept. 1995. ilus
Artículo en Español | BINACIS | ID: bin-22725

RESUMEN

Entre el 1 de enero de 1992 y el 31 de diciembre de 1993, se realizaron 4.586 tomografías abdóminopelvianas, de las cuales 142 (3,1 por ciento) presentaron masas gigantes (mayores de 10 cm). Las masas gigantes se presentaron con mayor frecuencia entre la sexta y séptima década de la vida. Del total de pacientes, 81 fueron de sexo femenino (57,04 por ciento) y 61 de sexo masculino (42,96 por ciento). Los signos y síntomas que acompañaron a cada paciente fueron muy variados como así también la localización de dichas masas. La TC tuvo una sensibilidad del 100 por ciento para confirmar y diagnosticar la presencia de masas gigantes. El análisis semiológico de estas masas por TC, nos ha permitido determinar el órgano comprometido en un 97,88 por ciento; caracterizar el contenido y arquitectura del tumor en el 100 por ciento de los casos y evocar la naturaleza de las lesiones, refiriéndose al carácter benigno y maligno de las mismas en el 92,25 por ciento (AU)


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Neoplasias Pélvicas/diagnóstico , Neoplasias Abdominales/diagnóstico , Diagnóstico Diferencial , Tomografía Computarizada por Rayos X/estadística & datos numéricos , Tomografía Computarizada por Rayos X/métodos , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/diagnóstico por imagen , Neoplasias Pélvicas/clasificación , Neoplasias Pélvicas/diagnóstico por imagen
20.
Vopr Onkol ; 33(6): 67-70, 1987.
Artículo en Ruso | MEDLINE | ID: mdl-3617602

RESUMEN

Long-term results of treatment of 126 cases of abdominal non-Hodgkin's lymphomas under 14 years are discussed. Survival doubled (from 24 to 49%) on application of modern methods of complex treatment. Such factors as stage, general symptoms, biologic activity and localization within the abdominal cavity at presentation were found to be of the highest prognostic value.


Asunto(s)
Neoplasias Abdominales/tratamiento farmacológico , Linfoma no Hodgkin/tratamiento farmacológico , Neoplasias Abdominales/clasificación , Neoplasias Abdominales/mortalidad , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Niño , Femenino , Humanos , Linfoma no Hodgkin/clasificación , Linfoma no Hodgkin/mortalidad , Masculino , Estadificación de Neoplasias , Pronóstico , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA